• Indiana Medical Board: Med Spas to Register Beginning January 1, 2027

    October 1, 2026

    The Indiana Medical Licensing Board announced on September 30, 2026, that medical spa registrations will officially go live on January 1, 2027. [...]

  • FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s

    September 24, 2026

    By Patrick O'Brien, JD, American Med Spa Association (AmSpa) The FDA's recent warning letter to Empower Pharmacy has drawn increased attention to [...]

  • Utah Makes Med Spa Recommendations to Lawmakers

    September 23, 2026

    By Patrick O’Brien, JD, American Med Spa Association (AmSpa) Recently the Utah Office of Professional License Review (OPLR) conducted a presentation identifying [...]

  • Pixel Tracking Lawsuits: What Medical Spas Need to Know

    September 14, 2026

    By Patrick O'Brien, JD, and Derek Hauk, American Med Spa Association Many medical spas, physician practices, and healthcare providers rely on website [...]

  • Rx prescription pad with pen, stethoscope

    Ohio Med Spa Fined $25,000 Following Prescription Drug Violations Investigation

    September 9, 2026

    An Ohio medical spa has agreed to pay $25,000 in fines and implement corrective measures after a state investigation found multiple violations [...]

  • Mississippi Boards Warn Against Use of ‘Research-Grade’ Peptides

    September 8, 2026

    The Mississippi State Board of Medical Licensure, Mississippi Board of Nursing and Mississippi Board of Pharmacy have issued a joint statement warning [...]

  • AI Is Reshaping the Med Spa Industry. Is Your Practice Ready for What That Means?

    August 21, 2026

    By Matt Rahman, President & Managing Partner at Safelink Consulting Inc.; and David Carter, Senior Director, Compliance at VIO Franchise Group Over [...]

  • South Carolina Medical Board Warns Against Use of Research-Grade Peptides

    August 18, 2026

    The South Carolina Board of Medical Examiners has issued a notice warning physicians that research-grade, non-FDA-approved peptides may not be used in [...]

  • New Louisiana Peptide Protections

    August 13, 2026

    The popularity of peptides, such as BPC-157, sermorelin, and TB-500 have exploded in the last few years. And recently an FDA advisory [...]

  • FDA Advisory Committee Recommends Adding Six of Seven Peptides to Compounding List

    July 24, 2026

    On Thursday, July 23, an FDA advisory committee recommended four popular peptide substances be added to the list of drugs that compounding [...]

  • Logo of the U.S. Food & Drug Administration (FDA)

    FDA Advisory Committee Recommends Adding BPC-157 to Compounding List

    July 23, 2026

    A closely watched FDA advisory committee has voted to recommend adding BPC-157 to the list of bulk drug substances that may be [...]

  • New IV Rules in Maine

    July 23, 2026

    By Patrick O'Brien, JD, General Counsel, American Med Spa Association (AmSpa) The Maine Boards of Medicine, Osteopathic Medicine, and Nursing have adopted [...]